• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受定期血液透析的尿毒症患者的骨骼闪烁显像变化

Scintigraphic skeletal changes in uremic patients on regular hemodialysis.

作者信息

Olgaard K, Heerfordt J, Madsen S

出版信息

Nephron. 1976;17(5):325-34. doi: 10.1159/000180738.

DOI:10.1159/000180738
PMID:787816
Abstract

99Tcm-polyphosphate (Tc-PP) bone scintigraphy was performed in 30 consecutive uremic patients on regular hemodialysis and compared with a normal control group. 27 of the patients (90%) had pathological accumulation on the scintigrams, while roentgenographic abnormalities were present in only 10 patients (33%), indicating that scintigraphy is superior to X-ray in the early detection of skeletal changes in uremic patients. In the group with the most pronounced uptake on the scintigrams there was a preponderance of previously kidney-transplanted patients, while no correlation could be demonstrated between the severity of the scintigraphic findings and the duration of the hemodialysis period, the anephric state of the patients, the underlying kidney disease or the sex. It is suggested that intensive glucocorticoid treatment, even of short duration in the previously kidney-transplanted patients, may aggravate uremic osteodystrophy.

摘要

对30例接受定期血液透析的尿毒症患者进行了99锝-多聚磷酸盐(Tc-PP)骨闪烁显像检查,并与正常对照组进行比较。27例患者(90%)的闪烁显像图上有病理聚集,而X线片异常仅见于10例患者(33%),这表明在尿毒症患者骨骼变化的早期检测中,闪烁显像优于X线检查。在闪烁显像图上摄取最为明显的患者组中,既往接受过肾移植的患者占多数,而闪烁显像结果的严重程度与血液透析时间、患者的无肾状态、潜在的肾脏疾病或性别之间均未显示出相关性。提示即使是对既往接受过肾移植的患者进行短期的强化糖皮质激素治疗,也可能会加重尿毒症骨营养不良。

相似文献

1
Scintigraphic skeletal changes in uremic patients on regular hemodialysis.接受定期血液透析的尿毒症患者的骨骼闪烁显像变化
Nephron. 1976;17(5):325-34. doi: 10.1159/000180738.
2
Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure.晚期肾衰竭未透析患者的骨闪烁显像变化
Clin Nephrol. 1979 Dec;12(6):273-8.
3
[Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].[骨骼闪烁扫描及一些骨转换标志物在血液透析患者肾性骨营养不良诊断中的应用]
Pol Arch Med Wewn. 2003 Sep;110(3):943-50.
4
[Uremic osteopathy in dialysis and transplantation with reference to bone scanning].[透析及移植中尿毒症性骨病与骨扫描的关系]
Verh Dtsch Ges Inn Med. 1974;80:736-8.
5
Scintigraphy in uremic bone disease.尿毒症骨病的闪烁扫描术
Nephron. 1976;17(5):321-4. doi: 10.1159/000180737.
6
[Potentials for the early diagnosis of renal osteodystrophy in patients with chronic kidney failure during treatment by systematic hemodialysis].[慢性肾衰竭患者在系统性血液透析治疗期间肾性骨营养不良的早期诊断潜力]
Urol Nefrol (Mosk). 1985 Mar-Apr(2):58-60.
7
[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].[慢性血液透析患者的放射性核素研究。用于评估和控制肾性骨病的骨闪烁显像]
Wien Klin Wochenschr. 1984 Apr 27;96(9):326-32.
8
[Clinico-scintigraphic studies of bone disease (renal osteodystrophy) in patients on chronic hemodialysis (preliminary report)].[慢性血液透析患者骨病(肾性骨营养不良)的临床闪烁扫描研究(初步报告)]
Vutr Boles. 1988;27(2):107-12.
9
[Importance of bone scanning with Tc 99m in the supervision of hemodialysis patients with chronic renal failure (author's transl)].锝99m骨扫描在慢性肾衰竭血液透析患者监测中的重要性(作者译)
Nephrologie. 1981;2(4):171-5.
10
Bone scintigraphy in renal osteodystrophy.
J Nucl Med. 1978 Dec;19(12):1289-96.

引用本文的文献

1
Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease.
Eur J Nucl Med. 1981;6(11):505-9. doi: 10.1007/BF00255882.
2
Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.
Eur J Nucl Med. 1982;7(4):152-4. doi: 10.1007/BF00443921.
3
Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.用1,25 - 二羟胆钙化醇治疗肾性骨营养不良。
Can Med Assoc J. 1981 Mar 1;124(5):577-83.
4
Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.
Eur J Nucl Med. 1981 Feb;6(2):63-7. doi: 10.1007/BF00253715.
5
Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.肾性骨营养不良的计算机定量骨闪烁显像观察
Eur J Nucl Med. 1984;9(9):419-25. doi: 10.1007/BF00295578.
6
Generalized soft tissue calcification in children and adolescents with end stage renal failure.终末期肾衰竭儿童及青少年的全身性软组织钙化
Eur J Pediatr. 1986 Sep;145(4):293-6. doi: 10.1007/BF00439403.
7
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.
Eur J Nucl Med. 1991;18(10):839-55. doi: 10.1007/BF00175066.
8
Noninvasive measurements of bone mass and their clinical significance.骨量的无创测量及其临床意义。
Calcif Tissue Res. 1978 Nov 10;26(1):1-3. doi: 10.1007/BF02013225.
9
Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index.代谢性骨病骨扫描的半定量解读:代谢指数的定义与验证
Eur J Nucl Med. 1979 Aug 1;4(4):287-9. doi: 10.1007/BF00304886.